What this means
This is a plan to follow sick patients over time and look for changes that might affect muscle loss. It has not reported any results yet, so it cannot tell us what helps.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 18 and over
- Where
- 1 site, including California
The science
- Registered title
- Identifying Modifiable PAtient Centered Therapeutics (IMPACT) Frailty
- Trial ID
- NCT04717869 ↗
- Phase
- Not applicable
- Study type
- observational
- Conditions
- Frailty, Sarcopenia
- What is tested
- Ultrasound, Biomarker Analysis, Frailty Index
- Sponsor
- University of California, Los Angeles
- Ages
- 18 Years to no maximum
- Dates
- First posted Jan 22, 2021 · updated Jan 30, 2026
Registry summary
Frailty, the decline in physical and cognitive reserves leading to vulnerability to stressors is increasingly being recognized as a public health concern. Although multiple measures exist that can identify frail patients, very little is known about how or when to intervene. Sarcopenia, or the degree of muscle wasting, is closely correlated to frailty and patient outcomes. This is a prospective cohort study of critically ill patients to identify modifiable risk factors of sarcopenia, as potential targets to reduce frailty.
Sites (1)
- Ronald Reagan UCLA Medical Center, Department of Anesthesiology & Perioperative Medicine, Los Angeles, California, United States